Philippe Brasseur

Summary

Publications

  1. ncbi Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal
    Piero L Olliaro
    UNICEF UNDP WB WHO Special Programme for Research and Training in Tropical Diseases TDR, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Malar J 7:234. 2008
  2. ncbi Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis
    Julien Zwang
    Shoklo Malaria Research Unit, Mae Sot, Thailand
    Malar J 8:203. 2009
  3. ncbi [One expert's opinion--strategies for treatment of uncomplicated P. falciparum malaria in Africa]
    P Brasseur
    , BP 1386,
    Med Trop (Mars) 64:437-8. 2004
  4. ncbi Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal
    Philippe Brasseur
    UR 077, IRD, Dakar, Senegal
    Malar J 6:150. 2007
  5. ncbi Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
    Jean Louis Ndiaye
    Department of Parasitology, Universite Cheikh Anta Diop, Dakar, Senegal
    Malar J 8:125. 2009
  6. ncbi Changing patterns of malaria during 1996-2010 in an area of moderate transmission in southern Senegal
    Philippe Brasseur
    Institut de recherche pour le developpement IRD, UMR 198, Rue Wagane Diouf Georges Pompidou, Dakar, Senegal
    Malar J 10:203. 2011
  7. ncbi Cryptosporidium contamination of surface and water supplies in Haiti
    Philippe Brasseur
    Unité de Recherche 077, Institut de Recherche pour le Developpement, Dakar, Senegal
    Arch Environ Occup Health 66:12-7. 2011
  8. ncbi [Treatment of malaria: outlook]
    Piero Olliaro
    Bull Acad Natl Med 191:1285-92. 2007
  9. ncbi Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria
    Walter R J Taylor
    Special Programme for Research and Training in Tropical Diseases, United Nations Children's Fund/World Bank/United Nations Development Programme/World Health Organization, Geneva, Switzerland
    Bull World Health Organ 84:956-64. 2006
  10. ncbi Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay
    Pierre Druilhe
    Bio medical Parasitology Unit, Institut Pasteur, 25 rue du Dr Roux, Paris 75015, France
    Antimicrob Agents Chemother 51:2112-6. 2007

Collaborators

Detail Information

Publications12

  1. ncbi Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal
    Piero L Olliaro
    UNICEF UNDP WB WHO Special Programme for Research and Training in Tropical Diseases TDR, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Malar J 7:234. 2008
    ..Indicators of implementation and effects of IPTp-SP were collected in a rural clinic in Southern Senegal...
  2. ncbi Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis
    Julien Zwang
    Shoklo Malaria Research Unit, Mae Sot, Thailand
    Malar J 8:203. 2009
    ..It was necessary to evaluate the efficacy of ACT, recently adopted by the World Health Organization (WHO) and deployed over 80 countries, in order to make an evidence-based drug policy...
  3. ncbi [One expert's opinion--strategies for treatment of uncomplicated P. falciparum malaria in Africa]
    P Brasseur
    , BP 1386,
    Med Trop (Mars) 64:437-8. 2004
  4. ncbi Efficacy and safety of artesunate plus amodiaquine in routine use for the treatment of uncomplicated malaria in Casamance, southern Sénégal
    Philippe Brasseur
    UR 077, IRD, Dakar, Senegal
    Malar J 6:150. 2007
    ..There are no data on the long term use of an artemisinin combination treatment in moderate or high transmission areas of Africa...
  5. ncbi Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria
    Jean Louis Ndiaye
    Department of Parasitology, Universite Cheikh Anta Diop, Dakar, Senegal
    Malar J 8:125. 2009
    ..To assess the efficacy and safety of this new combination and to define its optimum dosage regimen (once or twice daily) in the treatment of uncomplicated P. falciparum malaria, a multicentre clinical study was conducted...
  6. ncbi Changing patterns of malaria during 1996-2010 in an area of moderate transmission in southern Senegal
    Philippe Brasseur
    Institut de recherche pour le developpement IRD, UMR 198, Rue Wagane Diouf Georges Pompidou, Dakar, Senegal
    Malar J 10:203. 2011
    ..Since 2000, there has been a staggered deployment of artesunate-amodiaquine after parasitological confirmation; this was adopted nationally in 2006...
  7. ncbi Cryptosporidium contamination of surface and water supplies in Haiti
    Philippe Brasseur
    Unité de Recherche 077, Institut de Recherche pour le Developpement, Dakar, Senegal
    Arch Environ Occup Health 66:12-7. 2011
    ..The rate of contamination was 7/13 (54%) in water from public standpipes provided by the public company of water distribution. All surface water (4/4) collected was highly contaminated...
  8. ncbi [Treatment of malaria: outlook]
    Piero Olliaro
    Bull Acad Natl Med 191:1285-92. 2007
    ..The development and deployment of new products is both lengthy and complex...
  9. ncbi Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria
    Walter R J Taylor
    Special Programme for Research and Training in Tropical Diseases, United Nations Children's Fund/World Bank/United Nations Development Programme/World Health Organization, Geneva, Switzerland
    Bull World Health Organ 84:956-64. 2006
    ..CONCLUSION: The proposed method to use weight-for-age reference data from countries where malaria is endemic is a useful tool for designing age-based dosing regimens for antimalarial drugs for drug registration and field use...
  10. ncbi Improved assessment of plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzyme-linked immunosorbent assay
    Pierre Druilhe
    Bio medical Parasitology Unit, Institut Pasteur, 25 rue du Dr Roux, Paris 75015, France
    Antimicrob Agents Chemother 51:2112-6. 2007
    ..falciparum, i.e., in the range of 100 nM for chloroquine and 15 nM for pyronaridine. However, further studies are required to precisely define the cutoff for resistance and the sensitivity to each drug...
  11. ncbi Combination therapy for malaria: the way forward?
    Francois Nosten
    Shoklo Malaria Research Unit, Mae Sot, Thailand
    Drugs 62:1315-29. 2002
    ..Massive economic assistance will be needed to detect and treat adequately the estimated 500 million cases of malaria per year, but without radical action there is no prospect of 'Rolling Back' malaria...